Sandbox:DAMI: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
===Risk factors=== | ===Risk factors=== | ||
* Drugs (12765) | * Drugs (12765) | ||
** | ** Spironolactone | ||
** Cimetidine | |||
** Recombinant Human Growth Hormone | |||
** Estrogens | |||
** Human Chorionic gonadotropin | |||
** Anti-androgens | |||
** Gonadotropin Releasing hormone (GNRH) agonists | |||
** 5-alpha reductase inhibitors | |||
** Ketoconazole | ** Ketoconazole | ||
** steroids | ** steroids | ||
Revision as of 14:37, 18 May 2017
Gynecomastia
Risk factors
- Drugs (12765)
- Tumors
Common Risk Factors
Less Common Risk Factors
Causes
History and Symptoms
Physical Examination
References
- ↑ Braunstein GD (1993). "Gynecomastia". N Engl J Med. 328 (7): 490–5. doi:10.1056/NEJM199302183280708. PMID 8421478.